Articles tagged "Hepatitis B"

2015 American Transplant Congress
Validation of the Model for End-Stage Liver Disease Score Criteria in Liver Transplantation for Acute Flare Up of Hepatitis B in Non-Cirrhotic Liver
W.-C. Lee,¹ T.-J. Wu,¹ C.-F. Lee,¹ R.-S. Soong,¹ C.-H. Cheng,¹ H.-S. Chou,¹ T.-H. Wu,¹ K.-M. Chan,¹ Y.-C. Wang,¹ C.-S. Lee.²
¹Liver and Transplantation Surgery, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan; ²Hepatology, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan.
Background: Decision of necessity of urgent liver transplantation for acute flare up of hepatitis B in the patients without cirrhosis is difficult. The MELD score…
2015 American Transplant Congress
Comparison of Efficacy of Prophylactic Antivirus Therapies on Outcomes of Kidney Transplantation in Hepatitis B Virus Carriers
G. Chen, C. Wang, J. Qiu, J. Li, L. Chen.
Organ Transplant Center, The first affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Purpose To compare the efficacy between entecavir and lamivudine as prophylactic antivirus therapy on long-term outcomes of HBV carriers after kidney transplantation.Methods We retrospectively reviewed…
2015 American Transplant Congress
Active Immunization in Patients Transplanted for Hepatitis B Virus Related Liver Diseases: A Preliminary Report of a Prospective Study
W. Ju, A. Yang, Z. Guo, Q. Ren, D. Wang, A. Hu, Y. Ma, H. Jin, X. Zhu, X. He.
Organ Transplantation Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Aims: The aim of this study was to prospectively investigate the effectiveness and safety of procedural HBV vaccine in patients transplanted for hepatitis B virus…
2015 American Transplant Congress
Combined Hepatitic/Cholangiopathic Lesion in HIV-HCV Co-Infected Liver Transplant Recipients Associated With Graft Loss
J. Harbell,¹ A. Doherty,² L. Ferrell,² B. Barin,³ N. Terrault,¹ P. Stock.¹
¹Surgery, University of California, San Francisco, San Francisco, CA; ²Pathology, University of California, San Francisco, San Francisco, CA; ³EMMES Corporation, Rockville, MD.
Background: Co-infection with HIV and viral hepatitis results in poorer outcomes following liver transplantation. In this population, complex immune status, extensive drug regimens, and comorbid…
2015 American Transplant Congress
Pretransplant Hepatitis B Viral Infection Increased Risk of Death After Kidney Transplantation
J. Lee,¹ J.-H. Cho,² J. An,³ C.-D. Kim,² C. Ahn,⁴ I. Jung,³ D. Han, C. Lim,³ Y. Kim,⁴ Y. Kim, J. Lee.³
¹Internal Medicine, Hallym University Hangang Sacred Heart Hospital, Seoul, Republic of Korea; ²Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea; ³Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea; ⁴Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; ⁵Surgery, Ulsan University Seoul Asan Medical Center, Seoul, Republic of Korea.
Clinical outcomes have not been well evaluated in kidney transplant recipients (KTRs) with hepatitis B virus (HBV). Here, we aimed to investigate the recent posttransplant…
2015 American Transplant Congress
The Impact of Metabolic Syndrome and Prevalent Liver Disease on Living Donor Liver Transplantation: A Pressing Need to Expand the Pool
W. Al-hamoudi,^1,2 F. Abaalkhail,² A. Bendahmash,¹ N. Allam,² N. Almasri,² H. Al-Bahili,² M. Al-Sebayel,² D. Broering,² H. Elsiesy.²
¹Gastroenterology and Hepatology Department, King Saud University, Riyadh, Saudi Arabia; ²2Department of Liver Transplantation and Hepatobiliary Surgery, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Background and Aims: Organ shortage has been the ongoing obstacle to expand liver transplantation world-wide. Living donor liver transplantation (LDLT) was hoped to improve this…
2015 American Transplant Congress
Rituximab: Summarizing the Intracacies of the Black Box Warning and Expenses in Transplantation
N. Jandovitz, J. Lee, M. Bezman, D. Tsapepas.
Department of Pharmacy, NewYork-Presbyterian Hospital, New York, NY.
Post-transplant use of rituximab has become common, yet is associated with significant safety concerns and cost. Hepatitis B virus (HBV) reactivation following rituximab therapy poses…
2015 American Transplant Congress
Incidence of Hepatitis B Virus Reactivation in Kidney Transplant Patients Who Received Rituximab Administration
K. Omoto, M. Okumi, D. Toki, T. Shimizu, H. Ishida, K. Tanabe.
Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
OBJECTIVE:The efficacy of antiviral prophylaxis for rituximab (RIT)-associated hepatitis B virus (HBV) reactivation in patients with lymphoma has been recently reported. However, the immunological effect…